Showing 1 to 5 of 5 results
CRISPR Therapy Shows Promise but Faces Rollout Challenges
The first CRISPR-based therapy, approved in late 2023, offers a cure for previously untreatable diseases; however, slow rollout due to manufacturing and accreditation challenges highlights the need for regulatory adaptations and technological advancements in CRISPR enzyme delivery.
CRISPR Therapy Shows Promise but Faces Rollout Challenges
The first CRISPR-based therapy, approved in late 2023, offers a cure for previously untreatable diseases; however, slow rollout due to manufacturing and accreditation challenges highlights the need for regulatory adaptations and technological advancements in CRISPR enzyme delivery.
Progress
36% Bias Score
Pre-conception Genetic Testing: Potential to Reduce Severe Genetic Diseases in France
In France, 15,000-20,000 new cases of severe genetic diseases are diagnosed yearly, impacting 2-3% of the population. An Australian study showed pre-conception genetic testing identified 2% of 9,100 couples at risk, with 75% using this information for prenatal or preimplantation diagnosis, suggestin...
Pre-conception Genetic Testing: Potential to Reduce Severe Genetic Diseases in France
In France, 15,000-20,000 new cases of severe genetic diseases are diagnosed yearly, impacting 2-3% of the population. An Australian study showed pre-conception genetic testing identified 2% of 9,100 couples at risk, with 75% using this information for prenatal or preimplantation diagnosis, suggestin...
Progress
40% Bias Score
Diagnóstico genético identifica el origen de enfermedades neuromusculares en niños
Una nueva plataforma de diagnóstico genético ha identificado la causa de enfermedades neuromusculares en 23 niños, utilizando secuenciación del genoma en trío y del transcriptoma, logrando una tasa de éxito del 40% en un estudio de 58 pacientes pediátricos.
Diagnóstico genético identifica el origen de enfermedades neuromusculares en niños
Una nueva plataforma de diagnóstico genético ha identificado la causa de enfermedades neuromusculares en 23 niños, utilizando secuenciación del genoma en trío y del transcriptoma, logrando una tasa de éxito del 40% en un estudio de 58 pacientes pediátricos.
Progress
32% Bias Score
Russian Boy with Duchenne Muscular Dystrophy Needs $3 Million for Gene Therapy
Vladislav Paradov, a Russian boy, was diagnosed with Duchenne muscular dystrophy (DMD) at age three, a condition that until recently had no cure. His family is now fundraising $3 million for a new gene therapy treatment available in Dubai.
Russian Boy with Duchenne Muscular Dystrophy Needs $3 Million for Gene Therapy
Vladislav Paradov, a Russian boy, was diagnosed with Duchenne muscular dystrophy (DMD) at age three, a condition that until recently had no cure. His family is now fundraising $3 million for a new gene therapy treatment available in Dubai.
Progress
48% Bias Score
Genetic Testing Could Prevent Thousands of Severe Genetic Disease Births in France
In France, 15,000–20,000 new cases of severe genetic diseases are diagnosed annually; Australia's genetic testing program, identifying ~2% of couples at risk, resulted in 3/4 using this information for preventative measures, suggesting a potential for reducing severe genetic disease births in France...
Genetic Testing Could Prevent Thousands of Severe Genetic Disease Births in France
In France, 15,000–20,000 new cases of severe genetic diseases are diagnosed annually; Australia's genetic testing program, identifying ~2% of couples at risk, resulted in 3/4 using this information for preventative measures, suggesting a potential for reducing severe genetic disease births in France...
Progress
40% Bias Score
Showing 1 to 5 of 5 results